| Year |
Citation |
Score |
| 2023 |
Kjell J, Dulin JN, Warren PM. Editorial: Fighting for recovery on multiple fronts in spinal cord injury. Frontiers in Cellular Neuroscience. 17: 1178192. PMID 36998266 DOI: 10.3389/fncel.2023.1178192 |
0.657 |
|
| 2022 |
Kjell J, Svensson M. Advancing Peripheral Nerve Graft Transplantation for Incomplete Spinal Cord Injury Repair. Frontiers in Cellular Neuroscience. 16: 885245. PMID 35573831 DOI: 10.3389/fncel.2022.885245 |
0.48 |
|
| 2020 |
Kjell J, Götz M. Filling the Gaps - A Call for Comprehensive Analysis of Extracellular Matrix of the Glial Scar in Region- and Injury-Specific Contexts. Frontiers in Cellular Neuroscience. 14: 32. PMID 32153367 DOI: 10.3389/Fncel.2020.00032 |
0.341 |
|
| 2016 |
Kjell J, Olson L. Rat models of spinal cord injury: from pathology to potential therapies. Disease Models & Mechanisms. 9: 1125-1137. PMID 27736748 DOI: 10.1242/dmm.025833 |
0.688 |
|
| 2015 |
Kjell J, Olson L. Repositioning imatinib for spinal cord injury. Neural Regeneration Research. 10: 1591-3. PMID 26692852 DOI: 10.4103/1673-5374.167751 |
0.677 |
|
| 2015 |
Kjell J, Olson L, Abrams MB. Improved recovery from spinal cord injury in rats with chronic parvovirus serotype-1a infection. Spinal Cord. PMID 26690859 DOI: 10.1038/sc.2015.208 |
0.583 |
|
| 2015 |
Kjell J, Finn A, Hao J, Wellfelt K, Josephson A, Svensson CI, Wiesenfeld-Hallin Z, Eriksson U, Abrams M, Olson L. Delayed Imatinib Treatment for Acute Spinal Cord Injury: Functional Recovery and Serum Biomarkers. Journal of Neurotrauma. PMID 25914996 DOI: 10.1089/Neu.2014.3863 |
0.645 |
|
| 2014 |
Abrams MB, Nilsson I, Kjell J, Lewandowski S, Codeluppi S, Eriksson U, Olson L. Response to the report, "A re-assessment of treatment with a tyrosine kinase inhibitor (imatinib) on tissue sparing and functional recovery after spinal cord injury" by Sharp et al. Experimental Neurology. 257: 182-5. PMID 24825370 DOI: 10.1016/J.Expneurol.2014.04.025 |
0.453 |
|
| 2014 |
Codeluppi S, Fernandez-Zafra T, Sandor K, Kjell J, Liu Q, Abrams M, Olson L, Gray NS, Svensson CI, Uhlén P. Interleukin-6 secretion by astrocytes is dynamically regulated by PI3K-mTOR-calcium signaling. Plos One. 9: e92649. PMID 24667246 DOI: 10.1371/Journal.Pone.0092649 |
0.524 |
|
| 2014 |
Kjell J, Codeluppi S, Josephson A, Abrams MB. Spatial and cellular characterization of mTORC1 activation after spinal cord injury reveals biphasic increase mainly attributed to microglia/macrophages. Brain Pathology (Zurich, Switzerland). 24: 557-67. PMID 24576152 DOI: 10.1111/Bpa.12135 |
0.639 |
|
| 2014 |
Kjell J, Pernold K, Olson L, Abrams MB. Oral erlotinib, but not rapamycin, causes modest acceleration of bladder and hindlimb recovery from spinal cord injury in rats. Spinal Cord. 52: 186-90. PMID 24445976 DOI: 10.1038/Sc.2013.166 |
0.664 |
|
| 2013 |
Kjell J, Sandor K, Josephson A, Svensson CI, Abrams MB. Rat substrains differ in the magnitude of spontaneous locomotor recovery and in the development of mechanical hypersensitivity after experimental spinal cord injury. Journal of Neurotrauma. 30: 1805-11. PMID 23879467 DOI: 10.1089/Neu.2013.2998 |
0.663 |
|
| 2012 |
Abrams MB, Nilsson I, Lewandowski SA, Kjell J, Codeluppi S, Olson L, Eriksson U. Imatinib enhances functional outcome after spinal cord injury. Plos One. 7: e38760. PMID 22723886 DOI: 10.1371/Journal.Pone.0038760 |
0.678 |
|
| 2011 |
Codeluppi S, Gregory EN, Kjell J, Wigerblad G, Olson L, Svensson CI. Influence of rat substrain and growth conditions on the characteristics of primary cultures of adult rat spinal cord astrocytes. Journal of Neuroscience Methods. 197: 118-27. PMID 21345349 DOI: 10.1016/J.Jneumeth.2011.02.011 |
0.5 |
|
| Show low-probability matches. |